(Stroke. 1995;26:1983-1989.)
© 1995 American Heart Association, Inc.
Articles |
From the Department of Neurology, Center for Stroke Research (K.M.A.W., R.A.K., V.N., J.W.H., P.B., M.O.D., S.R.L.), and Department of Diagnostic Radiology (J.W., M.J., D.P.), Henry Ford Hospital and Health Sciences Center, Detroit, Mich/Case Western Reserve University, Cleveland, Ohio.
Correspondence to K.M.A. Welch, MD, Department of Neurology, K-11, Henry Ford Hospital and Health Sciences Center, 2799 W Grand Blvd, Detroit, MI 48202.
| Abstract |
|---|
|
|
|---|
Methods We developed an MR tissue signature model based on experimentally derived relationships of the apparent diffusion coefficient of water (ADCw) and T2 to ischemic brain tissue histopathology. In eight stroke patients we measured ADCw and T2 intensity using diffusion-weighted echo-planar imaging (DW-EPI). Tissue signature regions were defined, and theme maps of the ischemic focus at subacute time points after stroke onset were generated.
Results Five MR signatures were identified in human stroke foci: two that may predict either cell recovery or progression to necrosis, one that may mark the transition to cell necrosis, and two that may be markers of established cell necrosis.
Conclusions An MR tissue signature model of ischemic histopathology using ADCw and T2 can now be tested for its potential to predict reversible and identify irreversible cellular damage in human ischemic brain regions.
Key Words: cerebral ischemia, focal magnetic resonance imaging stroke, acute stroke outcome
| Introduction |
|---|
|
|
|---|
We report the measurement of ADCw in clinical stroke patients by DW-EPI and the measurement of T2I by T2-weighted MRI. A model of experimentally derived relationships of ADCw and T2 to histologically graded ischemic damage and the designated tissue signatures is described and used in the study of these patients. We used EIGENTOOL image analysis software and cluster analysis to generate tissue signature maps (theme maps) and to quantitate proportions of stroke regions with different tissue signature at subacute time points after stroke onset. We describe how we have identified these tissue signatures in human stroke and discuss the probability with which they may predict the eventual development of cerebral infarction.
| Model |
|---|
|
|
|---|
We assessed ischemic injury in anatomically defined zones by
neuronal, neuropil, and astrocyte grading and neuronal counting using
light microscopy. The results most cogent to the model are provided in
References 3 through 5 and are summarized in Table 1
.
The data obtained in these experiments indicated a reduction in
ADCw with gradation of change in terms of time and degree
depending on severity of ischemia.
|
The precise physical basis for this decline remains to be determined but, in brief, includes temperature effects, increased tortuosity of the extracellular diffusion paths, restriction by reduced cellular membrane permeability, shifts in water from extracellular to intracellular space, membrane depolarization, and cytotoxic edema.4 11 12 13 14 The decreased ADCw is associated with a specific threshold level of regional cerebral blood flow, similar to that which is associated with the loss of membrane potential,15 and is also associated with breakdown of energy metabolism, acidosis, cellular ionic shifts, and decreased Na+,K+-ATPase activity.16 17 Elevation of T2 seemed to follow a similar gradation of change that was, however, delayed compared with ADCw.
In the most heavily injured ischemic brain regions, the value of ADCw began to turn toward normal, coincident with the emergence of eosinophilic neurons and the beginning of neuronal necrosis. The subsequent rebound increase of ADCw, therefore, probably indicates a loss of cell membrane integrity (ie, it allows the unrestricted movement of water molecules) and cell necrosis. An elevated T2 distinguishes the "normal" ADCw (measured during the transition from low to high values) in damaged tissue from the normal ADCw in recovered tissue. High ADCw and high T2 together were associated with cellular necrosis. Even when T2 subsequently declined toward normal values, the ADCw remained elevated and a signature of cellular necrosis. A low ADCw before T2 elevation predicted cellular necrosis at 1 week with a high degree of probability.6 A low ADCw at 1 hour, however, was not predictive.
The relationships of ADCw and T2 changes
derived from groups of animals studied in Reference 3 are depicted
diagrammatically in Fig 1
. These changes are derived
from observations in a core of the ischemic focus because in
this region maximal ADCw and T2 changes are
exhibited throughout the course of ischemia. Thus, we can
assign six different MR signatures (A through F) to tissue
histopathology ranging from normal to necrosis. This model of
experimentally derived MR signatures of ischemic histopathology
may be tested in vivo for the potential to predict and mark the various
stages in the evolution of cellular damage. The provisions of the model
are summarized in Table 2
and as follows: (1) A low
ADCw in acute stroke may be associated with the potential
for cellular recovery or eventual cell necrosis dependent on time,
magnitude of initial ischemia, and subsequent degrees of
ischemia. Thus, measurement of ADCw alone, at a
single moment in time or as is often seen in the marginal zones of the
ischemic focus, has an uncertain probability of predicting
recovery or cell necrosis. (2) A low ADCw with high
T2 as ischemia progresses may have a probability of
predicting but is not a marker of eventual cell necrosis, although
events leading to irreversible cell injury may or may not have
commenced. (3) The transition from low to high ADCw values
probably marks the onset of irreversible cell necrosis. (4) High
ADCw and high or normal T2 is a marker of
established cell necrosis in the tissue.
|
|
| Subjects and Methods |
|---|
|
|
|---|
Techniques
Studies were conducted in a 3-T, 80-cm-bore magnet (patient
access bore is approximately 56 cm in diameter) with actively
shielded gradients of 20 mT/m (Magnex Scientific, Ltd) interfaced
to an SMIS imaging and spectroscopy console (Surrey Medical Imaging
Systems, Ltd). A quadrature high-pass birdcage head-imaging
coil was used for signal acquisition at 128 MHz. Patient head movement
was comfortably restricted, and ear plugs were used to control noise
discomfort. The patient's pulse rate and peripheral venous
PO2 were monitored by a pulse oximeter with
finger probe. Patients were continuously observed by video camera, and
a nurse was present throughout the procedure.
The studies used a DW-EPI sequence. In brief, a sequence was designed to acquire axial images of the whole brain one slice at a time and to allow separate application of diffusion gradients in three orthogonal directions. For technical reasons related to pixel distortion, only the DWI images along the z axis, ie, slice direction, were used for ADCw calculation. Control studies demonstrated that cardiac gating was unnecessary. Two trapezoidal diffusion gradients, equal in magnitude and duration, were applied in the vertical (y or anterior-posterior) direction, and phase-encoding gradients were applied in the horizontal (x or left-right) direction. For a 20-cm field of view and 200-kHz continuous readout sampling, a plateau readout gradient of 12 mT/m was required. Readout gradient trapezoids were produced with 320-microsecond ramps and 640-microsecond plateaus, resulting in 1.28-millisecond readout lobes and 82-millisecond total readout time. The spin echo was placed coincident with the zero-phase-encoded gradient echo. For a maximum diffusion gradient of b=600 s/mm2, a spin-echo time of 90 milliseconds was used, and the center of k-space sampling was placed asymmetrically at the 17th gradient echo (ie, 16 negative and 48 nonnegative k-space scan lines).
Rapid (15 seconds) FLASH (fast low-angle shot) scout images interleaved in two orthogonal planes (sagittal and transaxial) were used to position patients with the anterior-posterior commissure line at isocenter. Shimming was then performed to achieve nonlocalized water line widths of 20 Hz (0.16 ppm at 3 T) or less. Acquisition of DW-EPI began less than 10 minutes after the patient first entered the magnet bore.
Sixteen contiguous 5-mm slices (1 slice per second) were acquired in an interleaved order to minimize magnetization transfer and slice cross-talk effects. Four diffusion gradient strengths were applied (b=10, 207, 414, and 621 s/mm2) separately in each primary orthogonal direction. Reference scans were acquired without phase-encoding gradients, which allowed correction of echo position and phase before Fourier transformation reconstruction, to minimize image ghosts. A total of 384 DW-EPI scans (reference and imagex3 [gradient directions]x4 [b values]x16 [slices]) were acquired in 6.4 minutes. The total examination took 45 to 60 minutes.
The reference DW-EPI scans were used to determine gradient echo
positions and phases to correct the image scans. The samples digitized
during readout gradient ramps were discarded, and the even gradient
echoes were time-reversed. After phase correction, the asymmetrical
k-space samples from (-16 to +47)x
k were
conjugate-filled to range symmetrically from (-47 to +
47)x
k. The resulting 128x94 matrix was mildly Hanning filtered and
zero-filled, then 128x128 images were reconstructed by
two-dimensional Fourier transformation. Nominal image resolution
was 1.6 mmx2.1 mmx5 mm, giving a 17-µL nominal voxel.
Image Processing and Analysis
For the T2I we used the b=10 s/mm2
images (almost purely T2-weighted). ADCw maps
were constructed and combined with T2I images from which
cluster scattergrams were generated for subsequent cluster
analysis18 (Fig 2
).
Boundaries of the clustering regions were chosen with the use of an
iterative supervised procedure. We identified normal gray and white
matter clusters using the hemisphere contralateral to the stroke in the
image slice of interest. Upper and lower threshold values of the
T2 and ADCw were chosen. This normal range of
values was checked by creating a theme map of normal tissue by means of
projection of the cluster back onto the contralateral hemisphere
image. The threshold values for the normal tissue obtained in this way
were used to determine the boundaries for normal T2 and
ADCw for the whole slice scattergram and cluster
analysis (box A, Fig 2
). Once the boundaries
of the normal tissue box were established, the boundaries of the other
boxes were automatically established (boxes B through F, Fig 2
). A count of all pixels in each box was taken
together with the mean and SD of the values in each box cluster. Next,
theme maps of the distribution of each tissue signature in the stroke
focus and whole brain slice were constructed (Figs 2
and 3
). The theme
maps were used to establish whether signatures such as E (high
ADCw/high T2 also characterizes normal
CSF) were distributed in the stroke region or in a normal anatomic
distribution. For example, the cluster in box E, Fig 2
,
was distributed to the normal CSF compartments (not shown in the
figure) and not to the stroke focus.
|
|
Adopting the ADCw/T2I range of combined normal gray and white matter as normal control is considered necessary because of difficulties in distinguishing white from gray regions in the infarct. Also, because of having to combine gray and white matter values, means±SD could not be used to define control values because they overlap. Accordingly, the low ADCw pixels may be underestimated in gray matter to a small degree because the ADCw of white matter is lower than that of gray. Conversely, the number of pixels of high ADCw in white matter may be underestimated. This may mean that a "normal" ADCw in white matter that leads to a tissue signature designation of D may represent cell necrosis rather than transition to necrosis. Nevertheless, both represent an irreversible signature.
For each patient, we calculated (1) ADCw of normal tissue as the mean±SD of the normal range for gray/white matter based on the cluster analysis; (2) ADCw mean±SD of each tissue signature; (3) number of pixels of each signature in a single slice ischemic focus; (4) total number of abnormal pixels, ie, the area of the lesion in a slice; and (5) the percentage of each abnormal signature in the lesion area, ie, when P represents the total number of abnormal pixels, the proportion of each tissue signature in the total stroke area can be calculated. For example, where E is the number of pixels of tissue signature equivalent to cell necrosis, E/Px100=%E.
Because our purpose is to describe the model, the data evaluation is descriptive and was not subjected to statistical analysis.
| Results |
|---|
|
|
|---|
|
The majority of pixels in the stroke example were type C (low ADCw/high T2I). Type D (normal ADCw/high T2I), the transitional signature to necrosis, was distributed in central regions of the stroke. Tissue signature B was distributed in marginal, "penumbral" regions, which also included regions around the sylvian fissure.
Table 3
shows the tissue signatures we obtained from the
eight stroke patients. Most of the cases exhibited tissue signatures D
through F, which are markers of ongoing (D) to established (E, F)
necrosis and cell loss. The transitional phase from low
ADCw to high ADCw (D) for the most part
constituted a major percentage of the lesions. Furthermore, the mean
ADCw values in these regions were somewhat higher than the
mean calculated from the normal range data, suggesting that they were
increasing toward the upper threshold of normal.
One patient (case 1, Table 3
) appeared to show a
slower evolution of tissue signatures with high percentages of tissue
types B and C predominating. Two patients were studied twice. Patient 2
was studied at 4 days and again 2 months later. At the earliest time
point, the tissue signature of normal ADCw/high
T2 (D) constituted 72% of the stroke, and E and F, ie,
necrosis, constituted 28%. After 2 months, 85% of the infarct showed
the signatures of cellular necrosis (E and F), supporting the
transition of signature D toward necrosis, as postulated. Patient 3 was
studied at 24 hours and again at 48 hours. At 24 hours, 14% of the
lesion had a low ADCw (signature B), and 86% had the
signatures of necrosis (E and F). By 48 hours the proportion of tissue
that was classified as B became D (10%), ie, it had begun the
transition to necrosis, and the established necrosis (E and F) had
increased to 90%. There was a high percentage of tissue type F in the
stroke areas, often distributed around the rim of infarcts.
Analysis of histograms taken across the infarct margin (data
not shown) also showed that the elevated ADCw extended well
beyond the margin of T2 decline.
| Discussion |
|---|
|
|
|---|
In clinical practice, stroke patients cannot be studied at the precise time of stroke onset or serially over prolonged time periods so that moment to moment shifts in ADCw cannot be observed. Instead a "snapshot" of events is obtained at the earliest possible time and possibly on one or two other occasions during stroke evolution. Thus, based on experimental observations,3 at these less acute time points the ADCw in tissue destined for necrosis may be low, normal, or high as the ADCw shifts from low to high values, and there will be a heterogeneous distribution of ADCw values throughout central and peripheral regions. Accordingly, there must be some measure to discriminate a "normal" value of ADCw in its transition to high values in regions undergoing active cellular necrosis from that of normal ADCw values in recovering tissue. For these reasons at least one complementary measure is needed to characterize the evolving ischemic histopathology. The biophysical mechanisms of T2 change are better known than those of the ADCw,23 and the T2 correlates of histopathology, although regionally and dynamically limited, are established.24 25 26 These points influenced us to model the dynamic relationships between T2 and ADCw for their potential to predict and mark ischemic histopathology in human stroke.
We have identified five MR signatures in human stroke foci, of which, on the basis of our experimental model, two may predict either cell recovery or progression to necrosis and were more often distributed in stroke margins, one may mark the transition to necrosis, and two may be markers of established necrosis. The ADCw values in nonischemic tissue used as control were for the most part lower than reported with other techniques,19 20 21 with a fairly large SD in a few cases. This might be explained on the basis of the DW-EPI technique used to obtain the ADCw or other technical differences in the methods used to acquire data published by others (see below). Also, control data were obtained from all gray/white matter pixels in the contralateral hemisphere of the brain slice as opposed to the average of one normal locus. Diffuse changes in ADCw, unrelated to the presenting stroke but contributing biological variability, may be present. The individual variabilities in normal ADCw, however, do not influence tissue signatures because they are derived from ratios in the same subject.
In our clinical studies a low ADCw alone was more often distributed in margins of the stroke foci. A low ADCw can be caused by a spectrum of cellular change from potentially reversible metabolic deficit to destined cell necrosis.6 Thus, in clinical practice additional measures may be needed to discriminate degrees of recoverability, especially at later times of study.
It remains to be determined whether a low ADCw and high T2 has histopathological correlates in human stroke of (1) vasogenic edema in ischemic regions destined for recovery, (2) eventual cell necrosis, or (3) both (dependent on stroke region). If this information was known, it would have important implications for human stroke assessment. First, when brain regions are identified with this signature, although the cascade of events leading to cell necrosis may have begun, there still may be some potential benefit from cytoprotective drugs working at later points in the cascade, perhaps in more peripheral zones of the ischemic focus. Second, cellular necrosis may not have occurred yet in these brain regions, so that perhaps there will be less compliance of these tissues to hemorrhagic conversion or massive enhancement of vasogenic edema after reperfusion therapy.
We found regions characterized by a high ADCw and high T2 in our patients that we believe reflect cellular necrosis, but we also found evidence of significant proportions of tissue signature with a high ADCw and normal T2. We offer as possible explanation that the elevated ADCw represents cellular necrosis and that the T2 value is either reduced by the paramagnetic influence of iron from deoxygenated hemoglobin deposited by petechial hemorrhage in the tissue or could reflect selective neuronal necrosis unaccompanied by vasogenic edema.3 In support of the latter, tissue maps have shown the projection of this tissue signature often localizing to the periphery of the infarct.
The significance of an available predictor and marker of cell necrosis cannot be overemphasized. T2-weighted MRI has been unable to discriminate regions of necrosis from less involved tissue in a subacute ischemic focus, which is essential if MRI is to be used for other than diagnostic purposes in stroke patients. In combination with DWI, however, it opens the possibility of identifying tissue that may respond to cytoprotective therapy and perhaps extending the therapeutic window or opening it for those patients in whom the time of stroke onset cannot be determined with certainty. At a minimum, such tissue signatures might indicate whether the total lesion is beyond recovery. Extended studies of our tissue signature model in acute ischemia seem warranted, with serial observations to test the ability of the model to predict the eventual volume of infarction. Ideally the model should be tested against human autopsy material, but the practical limitations of rapidly accumulating such data are considerable. The model can be tested for predictability almost as well with the use of the T2-weighted image of the chronic established infarct as the "gold standard," and we are proceeding to do so.
| Selected Abbreviations and Acronyms |
|---|
|
| Acknowledgments |
|---|
Received April 10, 1995; revision received August 18, 1995; accepted August 18, 1995.
| References |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
A M BLAMIRE The technology of MRI -- the next 10 years? Br. J. Radiol., August 1, 2008; 81(968): 601 - 617. [Abstract] [Full Text] [PDF] |
||||
![]() |
S M. Maniega, M E Bastin, P A Armitage, A J Farrall, T K Carpenter, P J Hand, V Cvoro, C S Rivers, and J M Wardlaw Temporal evolution of water diffusion parameters is different in grey and white matter in human ischaemic stroke J. Neurol. Neurosurg. Psychiatry, December 1, 2004; 75(12): 1714 - 1718. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Mitsias, J. R. Ewing, M. Lu, M. M. Khalighi, M. Pasnoor, H. B. Ebadian, Q. Zhao, S. Santhakumar, M. A. Jacobs, N. Papamitsakis, et al. Multiparametric Iterative Self-Organizing MR Imaging Data Analysis Technique for Assessment of Tissue Viability in Acute Cerebral Ischemia AJNR Am. J. Neuroradiol., October 1, 2004; 25(9): 1499 - 1508. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Ozsunar, P. E. Grant, T. A. G. M. Huisman, P. W. Schaefer, O. Wu, A. G. Sorensen, W. J. Koroshetz, and R. G. Gonzalez Evolution of Water Diffusion and Anisotropy in Hyperacute Stroke: Significant Correlation between Fractional Anisotropy and T2 AJNR Am. J. Neuroradiol., May 1, 2004; 25(5): 699 - 705. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. L. Bykowski, L. L. Latour, and S. Warach More Accurate Identification of Reversible Ischemic Injury in Human Stroke by Cerebrospinal Fluid Suppressed Diffusion-Weighted Imaging Stroke, May 1, 2004; 35(5): 1100 - 1106. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Chen, S.-K. Song, W. Liu, M. McLean, J. S. Allen, J. Tan, S. A. Wickline, and X. Yu Remodeling of cardiac fiber structure after infarction in rats quantified with diffusion tensor MRI Am J Physiol Heart Circ Physiol, August 7, 2003; 285(3): H946 - H954. [Abstract] [Full Text] [PDF] |
||||
![]() |
P. D. Mitsias, M. A. Jacobs, R. Hammoud, M. Pasnoor, S. Santhakumar, N. I.H. Papamitsakis, H. Soltanian-Zadeh, M. Lu, M. Chopp, and S. C. Patel Multiparametric MRI ISODATA Ischemic Lesion Analysis: Correlation With the Clinical Neurological Deficit and Single-Parameter MRI Techniques Stroke, December 1, 2002; 33(12): 2839 - 2844. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.M. Wardlaw, S.L. Keir, M.E. Bastin, P.A. Armitage, and A.K. Rana Is diffusion imaging appearance an independent predictor of outcome after ischemic stroke? Neurology, November 12, 2002; 59(9): 1381 - 1387. [Abstract] [Full Text] [PDF] |
||||
![]() |
C. Z. Simonsen, L. Rohl, P. Vestergaard-Poulsen, C. Gyldensted, G. Andersen, and L. Ostergaard Final Infarct Size after Acute Stroke: Prediction with Flow Heterogeneity Radiology, October 1, 2002; 225(1): 269 - 275. [Abstract] [Full Text] [PDF] |
||||
![]() |
R. C. McKinstry, J. H. Miller, A. Z. Snyder, A. Mathur, G. L. Schefft, C. R. Almli, J. S. Shimony, S. I. Shiran, and J. J. Neil A prospective, longitudinal diffusion tensor imaging study of brain injury in newborns Neurology, September 24, 2002; 59(6): 824 - 833. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. E. Mullins, P. W. Schaefer, A. G. Sorensen, E. F. Halpern, H. Ay, J. He, W. J. Koroshetz, and R. G. Gonzalez CT and Conventional and Diffusion-weighted MR Imaging in Acute Stroke: Study in 691 Patients at Presentation to the Emergency Department Radiology, August 1, 2002; 224(2): 353 - 360. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. A. Copen, L. H. Schwamm, R. G. Gonzalez, O. Wu, C. B. Harmath, P. W. Schaefer, W. J. Koroshetz, and A. G. Sorensen Ischemic Stroke: Effects of Etiology and Patient Age on the Time Course of the Core Apparent Diffusion Coefficient Radiology, October 1, 2001; 221(1): 27 - 34. [Abstract] [Full Text] [PDF] |
||||
![]() |
I.-J. Huang, C.-Y. Chen, H.-W. Chung, D.-C. Chang, C.-C. Lee, S.-C. Chin, and M. Liou Time Course of Cerebral Infarction in the Middle Cerebral Arterial Territory: Deep Watershed versus Territorial Subtypes on Diffusion-weighted MR Images Radiology, October 1, 2001; 221(1): 35 - 42. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. Ishikawa, K. Yokoyama, T. Kuroiwa, and K. Makita Evolution of cerebral ischaemia induced by thromboembolism in rats detected by early sequential MR imaging Br. J. Anaesth., September 1, 2001; 87(3): 469 - 476. [Abstract] [Full Text] [PDF] |
||||
![]() |
T Murata, H Kimura, H Kado, M Omori, J Onizuka, T Takahashi, H Itoh, and Y Wada Neuronal damage in the interval form of CO poisoning determined by serial diffusion weighted magnetic resonance imaging plus 1H-magnetic resonance spectroscopy J. Neurol. Neurosurg. Psychiatry, August 1, 2001; 71(2): 250 - 253. [Abstract] [Full Text] [PDF] |
||||
![]() |
A. Rabinstein, S. Falcone, A. Forteza, and A. Forteza Diffusion-weighted Imaging Shows Cytotoxic and Vasogenic Edema in Eclampsia AJNR Am. J. Neuroradiol., June 1, 2001; 22(6): 1068 - 1070. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. G. Lansberg, V. N. Thijs, M. W. O'Brien, J. O. Ali, A. J. de Crespigny, D. C. Tong, M. E. Moseley, and G. W. Albers Evolution of Apparent Diffusion Coefficient, Diffusion-weighted, and T2-weighted Signal Intensity of Acute Stroke AJNR Am. J. Neuroradiol., April 1, 2001; 22(4): 637 - 644. [Abstract] [Full Text] |
||||
![]() |
O. Wu, W. J. Koroshetz, L. Ostergaard, F. S. Buonanno, W. A. Copen, R. G. Gonzalez, G. Rordorf, B. R. Rosen, L. H. Schwamm, R. M. Weisskoff, et al. Predicting Tissue Outcome in Acute Human Cerebral Ischemia Using Combined Diffusion- and Perfusion-Weighted MR Imaging Stroke, April 1, 2001; 32(4): 933 - 942. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Jacobs, Z. G. Zhang, R. A. Knight, H. Soltanian-Zadeh, A. V. Goussev, D. J. Peck, and M. Chopp A Model for Multiparametric MRI Tissue Characterization in Experimental Cerebral Ischemia With Histological Validation in Rat : Part 1 Stroke, April 1, 2001; 32(4): 943 - 949. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. A. Jacobs, P. Mitsias, H. Soltanian-Zadeh, S. Santhakumar, A. Ghanei, R. Hammond, D. J. Peck, M. Chopp, and S. Patel Multiparametric MRI Tissue Characterization in Clinical Stroke With Correlation to Clinical Outcome : Part 2 Stroke, April 1, 2001; 32(4): 950 - 957. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. R. Meyer, A. Gutierrez, B. Mock, D. Hebron, J. M. Prager, M. T. Gorey, and D. Homer High-b-value Diffusion-weighted MR Imaging of Suspected Brain Infarction AJNR Am. J. Neuroradiol., November 1, 2000; 21(10): 1821 - 1829. [Abstract] [Full Text] [PDF] |
||||
![]() |
S. L. Keir and J. M. Wardlaw Systematic Review of Diffusion and Perfusion Imaging in Acute Ischemic Stroke Stroke, November 1, 2000; 31(11): 2723 - 2731. [Abstract] [Full Text] [PDF] |
||||
![]() |
|